skip to main content
Idioma:
Refinado por: assunto: Medical Sciences remover assunto: Middle Aged remover assunto: Pharmacology. Drug Treatments remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

Gomez-Reino, Juan J ; Maneiro, Jose Ramon ; Ruiz, Jorge ; Roselló, Rosa ; Sanmarti, Raimon ; Romero, Ana Belen

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1861-1864 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
2
Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care
Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care
Material Type:
Artigo 		Adicionar ao Meu Espaço

Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

SOBRINO-VEGAS, Paz ; RODRIGUEZ-URREGO, Johana ; BERENGUER, Juan ; CARO-MURILLO, Ana María ; BLANCO, José Ramón ; VICIANA, Pompeyo ; MORENO, Santiago ; BERNARDINO, Ignacio ; DEL AMO, Julia ; CORIS

Antiviral therapy, 2012, Vol.17 (1), p.1-8 [Periódico revisado por pares]

London: International Medical Press

Texto completo disponível

Citações Citado por
3
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction

MARTINEZ, Esteban ; LARROUSSE, María ; PICH, Judit ; GATELL, José M ; PODZAMCZER, Daniel ; PEREZ, Ignacio ; GUTIERREZ, Félix ; LONCA, Montserrat ; BARRAGAN, Patricia ; DEULOFEU, Ramón ; CASAMITJANA, Roser ; MALLOLAS, Josep

AIDS (London), 2010-01, Vol.24 (3), p.F1-F9 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
4
Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008―2010
Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008―2010
Material Type:
Artigo 		Adicionar ao Meu Espaço

Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008―2010

JARRIN, Inma ; HERNANDEZ-NOVOA, Beatriz ; ALEJOS, Belén ; RIERA, Melchor ; NAVARRO, Gemma ; BERNARDINO, Jose Ignacio ; RIVERO, Maria ; DEL AMO, Julia ; MORENO, Santiago

Antiviral therapy, 2013-01, Vol.18 (2), p.161-170 [Periódico revisado por pares]

London: International Medical Press

Texto completo disponível

Citações Citado por
5
FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies
FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies

de la Rubia, Javier ; Regadera, Ana I. ; Martı́n, Guillermo ; Cervera, José ; Sanz, Guillermo F. ; Martı́nez, Jesús A. ; Jarque, Isidro ; Garcı́a, Inmaculada ; Andreu, Rafael ; Moscardó, Federico ; Jiménez, Carmen ; Mollá, Susana ; Benlloch, Luis ; Sanz, Miguel A.

Leukemia research, 2002-08, Vol.26 (8), p.725-730 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Failure of a short-term prednisone regimen to prevent nevirapine-associated rash : A double-blind placebo-controlled trial: The GESIDA 09/99 study
Failure of a short-term prednisone regimen to prevent nevirapine-associated rash : A double-blind placebo-controlled trial: The GESIDA 09/99 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Failure of a short-term prednisone regimen to prevent nevirapine-associated rash : A double-blind placebo-controlled trial: The GESIDA 09/99 study

KNOBEL, Hernando ; MIRO, José M ; BLANCO, José Luis ; LOCUTURA, Jaime ; DOMINGO, Pere ; RIVERO, Antonio ; MARQUEZ, Manuel ; FORCE, Luis ; GONZALEZ, Alicia ; DE MIGUEL, Veronica ; SANZ, José ; BOIX, Vicente

Journal of acquired immune deficiency syndromes (1999), 2001-09, Vol.28 (1), p.14-18 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.